Overview
Panome Bio is a multi-omics contract research organization offering next-generation metabolomics, discovery proteomics, transcriptomics, exposomics, and integrated multi-omics analysis for bioprocessing optimization and biomarker discovery. Their LC/MS platform with MassID™ engine detects up to 4x more compounds with superior reproducibility and no missing values compared to legacy methods. Services support applications in cultivated meat, neurodegeneration, cancer, metabolic disease, and environmental exposure profiling, delivering results in 4-6 weeks.
Frequently asked questions
- What omics services does Panome Bio provide?
- Panome Bio offers next-generation metabolomics, discovery proteomics, transcriptomics, exposomics (Discovery and Targeted), and integrated multi-omics analysis using LC/MS and AI-powered bioinformatics.
- What are the advantages of Panome Bio's metabolomics platform?
- Their platform detects 3.86x more compounds (3,003 vs. 777 per sample), identifies nearly 2x more metabolic pathways, achieves 2.4x better reproducibility (4.3% median CV), and produces complete data matrices with 0% missing values.
- What are the turnaround times and applications?
- Results are delivered in 4-6 weeks, supporting bioprocessing optimization (e.g., cultivated meat media analysis), biomarker discovery, and research in neurodegeneration, cancer, metabolic disease, exposomics, and product safety.